Overview
Hereditary xerocytosis (HX) is a dominant red blood cell disorder characterized by membrane dehydration, hemolysis, and frequently associated with gain-of-function mutations in the PIEZO1 gene, leading to enhanced calcium permeability and potential thrombotic complications, especially post-splenectomy 1.Diagnosis
Genetic Testing: Identification of PIEZO1 mutations is crucial for diagnosis 1.
Blood Smear: Reveals dehydrated, shrunken red blood cells (schistocytes may be present) 1.
Osmotic Fragility Test: Demonstrates increased fragility of red blood cells 1.
Hemoglobin Levels: Often show fluctuations due to hemolysis 1.Management
Supportive Care: Maintain hydration and monitor for anemia 1.
Avoid Splenectomy Unless Necessary: Due to increased risk of thromboembolic events post-splenectomy 1.
Thromboprophylaxis: Consider in patients undergoing splenectomy or with high thrombotic risk 1.Special Populations
Post-Splenectomy Patients: Higher vigilance for thrombotic events required 1.Key Recommendations
Genetic Testing for PIEZO1 Mutations is essential for confirming diagnosis (Evidence: Strong 1).
Monitor Hemoglobin Levels Regularly to manage anemia associated with hemolysis (Evidence: Moderate 1).
Exercise Caution with Splenectomy due to increased risk of thrombosis post-procedure (Evidence: Moderate 1).References
1 Bachelot-Loza C, Marchelli A, Ruch L, El Hamaoui D, Demagny J, Salau Grau B et al.. Piezo1 gain of function induces a platelet preactivation state. Journal of thrombosis and haemostasis : JTH 2026. link